SUBSCRIBERS
Pfizer sues Johnson & Johnson over anti-competitive tactics
It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug
Add BT as a preferred sourcePublished Thu, Sep 21, 2017 · 09:50 PM
Washington
A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.
Pfizer filed a lawsuit on Wednesday against fellow pharmaceutical giant Johnson & Johnson for using "anti-competitive" tactics to squash its cheaper version of a powerful rheumatoid arthritis drug.
Share with us your feedback on BT's products and services
